Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Neuromuscular Blockade Reversal With Sugammadex on Oxygenation, Pain and Arousal States in the Post Anesthesia Care Unit

NCT02243943 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.

NCT NCT02243943
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02243943 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Neuromuscular Blockade Reversal With Sugammadex on Oxygenation, Pain and Arousal States in the Post Anesthesia Care Unit
Lead sponsor
Leiden University Medical Center
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2014
Completion date
April 30, 2016
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative respiratory condition